All Stories

  1. Prognostic factors associated with long-term mortality in 1445 patients with nontuberculous mycobacterial pulmonary disease: a 15-year follow-up study

    Article • European Respiratory Journal, October 2019, European Respiratory Society (ERS)

    Won-Jung Koh

  2. Managing antibiotic resistance in nontuberculous mycobacterial pulmonary disease: challenges and new approaches

    Article • Expert Review of Respiratory Medicine, July 2019, Taylor & Francis

    Won-Jung Koh

  3. Unresolved issues in treatment outcome definitions for nontuberculous mycobacterial pulmonary disease

    Article • European Respiratory Journal, February 2019, European Respiratory Society (ERS)

    Won-Jung Koh

  4. Development of Macrolide Resistance and Reinfection in Refractory Mycobacterium avium Complex Lung Disease

    Article • American Journal of Respiratory and Critical Care Medicine, November 2018, American Thoracic Society

    Won-Jung Koh

  5. Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex

    Article • Antimicrobial Agents and Chemotherapy, August 2018, ASM Journals

    Won-Jung Koh

  6. Mutations ingyrAandgyrBin Moxifloxacin-ResistantMycobacterium aviumComplex andMycobacterium abscessusComplex Clinical Isolates

    Article • Antimicrobial Agents and Chemotherapy, June 2018, ASM Journals

    Won-Jung Koh

  7. Amikacin Inhalation as Salvage Therapy for Refractory Nontuberculous Mycobacterial Lung Disease

    Article • Antimicrobial Agents and Chemotherapy, April 2018, ASM Journals

    Won-Jung Koh

  8. Limited Effect of Later-Generation Fluoroquinolones in the Treatment of Ofloxacin-Resistant and Moxifloxacin-Susceptible Multidrug-Resistant Tuberculosis

    Article • Antimicrobial Agents and Chemotherapy, December 2017, ASM Journals

    Won-Jung Koh

  9. Outcomes of Mycobacterium avium complex lung disease based on clinical phenotype

    Article • European Respiratory Journal, September 2017, European Respiratory Society (ERS)

    Won-Jung Koh

  10. Clinical Characteristics and Treatment Outcomes of Patients with Acquired Macrolide-Resistant Mycobacterium abscessus Lung Disease

    Article • Antimicrobial Agents and Chemotherapy, July 2017, ASM Journals

    Won-Jung Koh

  11. Development of a One-Step Multiplex PCR Assay for Differential Detection of Major Mycobacterium Species

    Article • Journal of Clinical Microbiology, June 2017, ASM Journals

    Won-Jung Koh

  12. Functional status and mortality prediction in community-acquired pneumonia

    Article • Respirology, May 2017, Wiley

    Won-Jung Koh, Hye Yun Park

  13. Clofazimine-Containing Regimen for the Treatment of Mycobacterium abscessus Lung Disease

    Article • Antimicrobial Agents and Chemotherapy, March 2017, ASM Journals

    Won-Jung Koh

  14. Airflow limitation severity and post-operative pulmonary complications following extra-pulmonary surgery in COPD patients

    Article • Respirology, January 2017, Wiley

    Won-Jung Koh, Hye Yun Park

  15. COPD assessment test score and serum C-reactive protein level in stable COPD patients

    Article • International Journal of Chronic Obstructive Pulmonary Disease, December 2016, Dove Medical Press

    Won-Jung Koh, Byeong-Ho Jeong, Hyun Lee, Hye Yun Park

  16. Clinical Characteristics and Treatment Outcomes of Patients with Macrolide-Resistant Mycobacterium massiliense Lung Disease

    Article • Antimicrobial Agents and Chemotherapy, November 2016, ASM Journals

    Won-Jung Koh

  17. Effects of long-term bronchodilators in bronchiectasis patients with airflow limitation based on bronchodilator response at baseline

    Article • International Journal of Chronic Obstructive Pulmonary Disease, November 2016, Dove Medical Press

    Won-Jung Koh, Byeong-Ho Jeong, Hyun Lee, Hye Yun Park

  18. Clinical Characteristics, Treatment Outcomes, and Resistance Mutations Associated with Macrolide-Resistant Mycobacterium avium Complex Lung Disease

    Article • Antimicrobial Agents and Chemotherapy, August 2016, ASM Journals

    Won-Jung Koh

  19. Peak Plasma Concentration of Azithromycin and Treatment Responses in Mycobacterium avium Complex Lung Disease

    Article • Antimicrobial Agents and Chemotherapy, August 2016, ASM Journals

    Won-Jung Koh

  20. Comorbidity as a contributor to frequent severe acute exacerbation in COPD patients

    Article • International Journal of Chronic Obstructive Pulmonary Disease, August 2016, Dove Medical Press

    Won-Jung Koh, Hye Yun Park

  21. Association of blood eosinophils and plasma periostin with FEV1 response after 3-month inhaled corticosteroid and long-acting beta2-agonist treatment in stable COPD patients

    Article • International Journal of Chronic Obstructive Pulmonary Disease, December 2015, Dove Medical Press

    Professor Woo Jin Kim, Won-Jung Koh, Hye Yun Park

  22. Treatment Outcomes with Fluoroquinolone-Containing Regimens for Isoniazid-Resistant Pulmonary Tuberculosis

    Article • Antimicrobial Agents and Chemotherapy, November 2015, ASM Journals

    Won-Jung Koh

  23. A proposal for an individualized pharmacogenetic-guided isoniazid dosage regimen for patients with tuberculosis

    Article • Drug Design Development and Therapy, September 2015, Dove Medical Press

    Won-Jung Koh

  24. Response to Switch from Intermittent Therapy to Daily Therapy for Refractory Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease

    Article • Antimicrobial Agents and Chemotherapy, May 2015, ASM Journals

    Won-Jung Koh

  25. Delamanid when other anti-tuberculosis-treatment regimens failed due to resistance or tolerability

    Article • Expert Opinion on Pharmacotherapy, October 2014, Informa Healthcare

    Won-Jung Koh

  26. Effect of Rifampin and Rifabutin on Serum Itraconazole Levels in Patients with Chronic Pulmonary Aspergillosis and Coexisting Nontuberculous Mycobacterial Infection

    Article • Antimicrobial Agents and Chemotherapy, October 2014, ASM Journals

    Won-Jung Koh

  27. Serodiagnosis of Mycobacterium avium Complex and Mycobacterium abscessus Complex Pulmonary Disease by Use of IgA Antibodies to Glycopeptidolipid Core Antigen

    Article • Journal of Clinical Microbiology, June 2013, ASM Journals

    Won-Jung Koh

  28. First Case of Pulmonary Disease Caused by a Mycobacterium avium Complex Strain of Presumed Veterinary Origin in an Adult Human Patient

    Article • Journal of Clinical Microbiology, April 2013, ASM Journals

    Won-Jung Koh

  29. Treatment of Refractory Mycobacterium avium Complex Lung Disease with a Moxifloxacin-Containing Regimen

    Article • Antimicrobial Agents and Chemotherapy, March 2013, ASM Journals

    Won-Jung Koh

  30. Successful Treatment of Mycobacterium massiliense Lung Disease with Oral Antibiotics Only

    Article • Antimicrobial Agents and Chemotherapy, November 2012, ASM Journals

    Won-Jung Koh